Skip to main content
Erschienen in:

02.02.2024 | Herzinsuffizienz | CME

Kardiorenales Syndrom bei geriatrischen Patienten

verfasst von: Prim. Dr. Peter Dovjak

Erschienen in: Zeitschrift für Gerontologie und Geriatrie | Ausgabe 2/2024

zum CME-Kurs Einloggen, um Zugang zu erhalten

Zusammenfassung

Die ungünstige gegenseitige Beeinflussung der Nieren- und Herzfunktion bei akutem oder chronischem Nieren- und/oder Herzversagen definiert das kardiorenale Syndrom (KRS) seit einer Konsensuskonferenz 2004. Die pathophysiologischen Überlegungen und die sich daraus ergebenden Therapieansätze bedingen die Einteilung in 5 Typen. Eine hohe Prävalenz zeigt das Syndrom bei geriatrischen Patienten. Die Wechselwirkungen der Medikation auf das eine oder andere Organ erfordern beim KRS ein Zusammenspiel der Therapiemodalitäten, um die Prognose zu verbessern und akute Verschlechterungen zu verhindern. Die genaue Kenntnis der jeweiligen Indikationen, Differenzialtherapie und Spezifika im Umgang mit dem KRS kann die bisherige Unterbehandlung aus Sorge von Nebenwirkungen verbessern.
Literatur
1.
Zurück zum Zitat Forman DE, Butler J, Wang Y, Abraham WT, O’Connor CM, Gottlieb SS et al (2004) Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43(1):61–67CrossRefPubMed Forman DE, Butler J, Wang Y, Abraham WT, O’Connor CM, Gottlieb SS et al (2004) Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43(1):61–67CrossRefPubMed
2.
Zurück zum Zitat Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J et al (2007) High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail 13(6):422–430CrossRefPubMed Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J et al (2007) High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail 13(6):422–430CrossRefPubMed
3.
Zurück zum Zitat Butler J, Forman DE, Abraham WT, Gottlieb SS, Loh E, Massie BM et al (2004) Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart Hosp J 147(2):331–338CrossRef Butler J, Forman DE, Abraham WT, Gottlieb SS, Loh E, Massie BM et al (2004) Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart Hosp J 147(2):331–338CrossRef
4.
Zurück zum Zitat National Heart, Lung and Blood Institute (2004) https://www.nhlbi.nih.gov/events/2004/cardio-renal-connections-heart-failure-and-cardiovascular-disease National Heart, Lung and Blood Institute (2004) https://​www.​nhlbi.​nih.​gov/​events/​2004/​cardio-renal-connections-heart-failure-and-cardiovascular-disease
5.
Zurück zum Zitat Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM et al (2010) Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J 31(6):703–711CrossRefPubMed Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM et al (2010) Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J 31(6):703–711CrossRefPubMed
7.
Zurück zum Zitat Zannad F, Rossignol P (2018) Cardiorenal syndrome revisited. Circulation 138(9):929–944CrossRefPubMed Zannad F, Rossignol P (2018) Cardiorenal syndrome revisited. Circulation 138(9):929–944CrossRefPubMed
8.
Zurück zum Zitat McDonagh TA, Metra M, Adamo M et al (2022) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. European J of Heart Fail 24(1):4–131CrossRef McDonagh TA, Metra M, Adamo M et al (2022) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. European J of Heart Fail 24(1):4–131CrossRef
9.
Zurück zum Zitat Mehta RL, Kellum JA, Shah SV et al (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11(2):R31CrossRefPubMedPubMedCentral Mehta RL, Kellum JA, Shah SV et al (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11(2):R31CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Levey AS, de Jong PE, Coresh J et al (2011) The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 80(1):17–28CrossRefPubMed Levey AS, de Jong PE, Coresh J et al (2011) The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 80(1):17–28CrossRefPubMed
11.
Zurück zum Zitat Kidney Disease: Improving Global Outcomes (KDIGO) (2022) Clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int 102 (5S):S1–S127CrossRef Kidney Disease: Improving Global Outcomes (KDIGO) (2022) Clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int 102 (5S):S1–S127CrossRef
12.
Zurück zum Zitat Levin A, Stevens PE, Bilous, RW et al. (2013) Kidney disease: Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3(1):1–150 Levin A, Stevens PE, Bilous, RW et al. (2013) Kidney disease: Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3(1):1–150
13.
Zurück zum Zitat Delalić Đ, Brežni T, Prkačin I (2023) Diagnostic value and utility of commonly used biomarkers of cardiac and renal function in cardiorenal syndromes: a narrative review. Biochem Med 33(3):30502 Delalić Đ, Brežni T, Prkačin I (2023) Diagnostic value and utility of commonly used biomarkers of cardiac and renal function in cardiorenal syndromes: a narrative review. Biochem Med 33(3):30502
14.
Zurück zum Zitat Rice JA, Brewer J, Speaks T et al (2021) The POCUS consult: how point of care ultrasound helps guide medical decision making. Int J Gen Med 14:9789–9806CrossRefPubMedPubMedCentral Rice JA, Brewer J, Speaks T et al (2021) The POCUS consult: how point of care ultrasound helps guide medical decision making. Int J Gen Med 14:9789–9806CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Salvador DR, Rey NR, Ramos GC, Punzalan FE (2005) Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev 3:CD3178 Salvador DR, Rey NR, Ramos GC, Punzalan FE (2005) Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev 3:CD3178
16.
Zurück zum Zitat Mullens W, Dauw J, Martens P et al (2022) Acetazolamide in acute decompensated heart failure with volume overload. N Engl J Med 387(13):1185–1195CrossRefPubMed Mullens W, Dauw J, Martens P et al (2022) Acetazolamide in acute decompensated heart failure with volume overload. N Engl J Med 387(13):1185–1195CrossRefPubMed
17.
Zurück zum Zitat Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129–2200CrossRefPubMed Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129–2200CrossRefPubMed
18.
Zurück zum Zitat Caton JB, Jimenez S, Wang SX (2021) Things we do for no reason™: fluid restriction for the management of acute decompensated heart failure in patients with reduced ejection fraction. J Hosp Med 16(12):754–756CrossRefPubMed Caton JB, Jimenez S, Wang SX (2021) Things we do for no reason™: fluid restriction for the management of acute decompensated heart failure in patients with reduced ejection fraction. J Hosp Med 16(12):754–756CrossRefPubMed
19.
Zurück zum Zitat Rangaswami J, Bhalla V, Blair JEA et al (2019) Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation 139(16):e840–e78CrossRefPubMed Rangaswami J, Bhalla V, Blair JEA et al (2019) Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation 139(16):e840–e78CrossRefPubMed
20.
Zurück zum Zitat Nohria A, Lewis E, Stevenson LW (2002) Medical management of advanced heart failure. JAMA 287(5):628–640CrossRefPubMed Nohria A, Lewis E, Stevenson LW (2002) Medical management of advanced heart failure. JAMA 287(5):628–640CrossRefPubMed
21.
Zurück zum Zitat Dovjak P (2022) Frailty in older adults with heart disease. Z Gerontol Geriatr 55(6):465–470CrossRefPubMed Dovjak P (2022) Frailty in older adults with heart disease. Z Gerontol Geriatr 55(6):465–470CrossRefPubMed
22.
Zurück zum Zitat Dovjak P (2016) Sarcopenia in cases of chronic and acute illness. A mini-review. Z Gerontol Geriatr 49(2):100–106CrossRefPubMed Dovjak P (2016) Sarcopenia in cases of chronic and acute illness. A mini-review. Z Gerontol Geriatr 49(2):100–106CrossRefPubMed
23.
Zurück zum Zitat Onuigbo MA (2014) RAAS inhibition and cardiorenal syndrome. Curr Hypertens Rev 10(2):107–111CrossRefPubMed Onuigbo MA (2014) RAAS inhibition and cardiorenal syndrome. Curr Hypertens Rev 10(2):107–111CrossRefPubMed
24.
Zurück zum Zitat Liang W, He X, Xue R et al (2020) Association of hyponatraemia and renal function in type 1 cardiorenal syndrome. Eur J Clin Invest 50(9):e13269CrossRefPubMed Liang W, He X, Xue R et al (2020) Association of hyponatraemia and renal function in type 1 cardiorenal syndrome. Eur J Clin Invest 50(9):e13269CrossRefPubMed
25.
Zurück zum Zitat Palmer BF, Clegg DJ (2017) Diagnosis and treatment of hyperkalemia. Cleve Clin J Med 84(12):934–942CrossRefPubMed Palmer BF, Clegg DJ (2017) Diagnosis and treatment of hyperkalemia. Cleve Clin J Med 84(12):934–942CrossRefPubMed
26.
Zurück zum Zitat Buffington MA, Abreo K (2016) Hyponatremia: a review. J Intensive Care Med 31(4):223–236CrossRefPubMed Buffington MA, Abreo K (2016) Hyponatremia: a review. J Intensive Care Med 31(4):223–236CrossRefPubMed
27.
Zurück zum Zitat Kraut JA, Madias NE (2012) Treatment of acute metabolic acidosis: a pathophysiologic approach. Nat Rev Nephrol 8(10):589–601CrossRefPubMed Kraut JA, Madias NE (2012) Treatment of acute metabolic acidosis: a pathophysiologic approach. Nat Rev Nephrol 8(10):589–601CrossRefPubMed
28.
Zurück zum Zitat Achanti A, Szerlip HM (2023) Acid-base disorders in the critically Ill patient. Clin J Am Soc Nephrol 18(1):102–112CrossRefPubMed Achanti A, Szerlip HM (2023) Acid-base disorders in the critically Ill patient. Clin J Am Soc Nephrol 18(1):102–112CrossRefPubMed
29.
Zurück zum Zitat House AA, Haapio M, Lassus J, Bellomo R, Ronco C (2011) Pharmacological management of cardiorenal syndromes. Int J Nephrol 2011:630809CrossRefPubMedPubMedCentral House AA, Haapio M, Lassus J, Bellomo R, Ronco C (2011) Pharmacological management of cardiorenal syndromes. Int J Nephrol 2011:630809CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat McMurray JJ, Packer M, Solomon SD (2014) Neprilysin inhibition for heart failure. N Engl J Med 371(24):2336–2337PubMed McMurray JJ, Packer M, Solomon SD (2014) Neprilysin inhibition for heart failure. N Engl J Med 371(24):2336–2337PubMed
32.
Zurück zum Zitat Riksen NP, Hausenloy DJ, Yellon DM (2008) Erythropoietin: ready for prime-time cardioprotection. Trends Pharmacol Sci 29(5):258–267CrossRefPubMed Riksen NP, Hausenloy DJ, Yellon DM (2008) Erythropoietin: ready for prime-time cardioprotection. Trends Pharmacol Sci 29(5):258–267CrossRefPubMed
33.
Zurück zum Zitat Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H et al (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361(25):2436–2448CrossRefPubMed Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H et al (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361(25):2436–2448CrossRefPubMed
34.
Zurück zum Zitat Doumani G, Spanos G, Theofilis P, Vordoni A, Kalaitzidis RG (2023) Cardiorenal syndrome and iron supplementation-more benefits than risks: a narrative review. Int Urol Nephrol Doumani G, Spanos G, Theofilis P, Vordoni A, Kalaitzidis RG (2023) Cardiorenal syndrome and iron supplementation-more benefits than risks: a narrative review. Int Urol Nephrol
35.
Zurück zum Zitat McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2022;24(1):4-131.CrossRefPubMed McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2022;24(1):4-131.CrossRefPubMed
Metadaten
Titel
Kardiorenales Syndrom bei geriatrischen Patienten
verfasst von
Prim. Dr. Peter Dovjak
Publikationsdatum
02.02.2024

Weitere Artikel der Ausgabe 2/2024

Zeitschrift für Gerontologie und Geriatrie 2/2024 Zur Ausgabe

Journal Club

Journal Club

Mitteilungen der DGGG

Mitteilungen der DGGG